期刊文献+

替加环素、米诺环素、多黏菌素B对碳青霉烯类敏感性降低和不敏感鲍曼不动杆菌体外抗菌活性 被引量:19

In vitro activity of tigecycline,minocycline and polymyxin B against Acinetobacter baumannii with decreased susceptibility or nonsusceptibility to carbapenems
下载PDF
导出
摘要 目的调查替加环素、米诺环素、多黏菌素B等对碳青霉烯类抗生素敏感性降低鲍曼不动杆菌(CDSAB)和碳青霉烯不敏感鲍曼不动杆菌(CNSAB)体外抗菌活性,为临床治疗该类菌感染提供依据。方法采用琼脂稀释法检测替加环素、米诺环素、多黏菌素B等15种抗菌药物对2002-2009年深圳市人民医院临床分离56株CDSAB(美罗培南和亚胺培南MIC=1~4mg/L)和178株CNSAB(美罗培南或亚胺培南MIC≥8mg/L)的最低抑菌浓度(MIC),采用WHONET5.6软件分析处理数据。结果多黏菌素B对CDSAB和CNSAB体外抗菌活性最高,细菌对其均100%敏感,MIC50和MIC90均为1mg/L,其次为替加环素和米诺环素,约80%CDSAB对二者敏感或中介,MIC50/MIC90分别为4/8mg/L和8/16mg/L;约95%CNSAB对替加环素和米诺环素敏感或中介,MIC50/MIC90分别为4/4mg/L和4/8mg/L。结论多黏菌素B、替加环素和米诺环素对碳青霉烯类抗生素敏感性降低和不敏感鲍曼不动杆菌具有较强的体外抗菌活性。 Objective The in vitro activity of tigecycline, minocycline, polymyxin B and other comparators against Acinetobact-er baumannii with decreased susceptibility or nonsusceptihility to carbapenems was compared {or better clinical management of such infections. Methods Agar dilution method was used to determine the minimum inhibitory concentrations (MICs) of 15 an-timicrobial agents against A. baumannii collected during the period from 2002 to 2009 in Shenzhen People's Hospital. A total of 56 strains were found with decreased susceptibility to carbapenems, which was defined as imipenem MIC = 1 to 4 mg/L and meropenem MIC = 1 to 4 mg/L. Overall, 178 strains were identified as carbapenem-non-susceptible A. baumannii, which was defined as imipenem MIC ≥ 8 mg/L or meropenem MIC ≥ 8 mg/L. The data were analyzed by WHONET 5.6 software. Results Polymyxin B showed the highest activity against the A. baurnctnnil strains with decreased susceptihility or nonsuscepti-bility to carbapenems. All the strains were susceptible to poiymyxin B in vitro. Both MIC50 and MIC90 values were 1 mg/L.Tigecycline and minocycline could inhibit about 80% of the A. baumannii strains with decreased susceptibility to carbapenems. The MIC50/MIC90 ratio was 4/8 mg/L and 8/ 16mg/L, respectively. About 95% of the carbapenem-non-susceptible A. baumannii strains were susceptible or inter-mediate to tigecycline and minocycline. The MICso/MICgo ratio was 4/4 mg/L and 4/8 mg/L. Conclusions Polymyxin B, tigecycline and minocycline have relatively higher antibac-terial activity against the A. baumannii strains with de-creased susceptibility or nonsusceptibility to carbapenems.
出处 《中国感染与化疗杂志》 CAS 北大核心 2014年第1期42-46,共5页 Chinese Journal of Infection and Chemotherapy
基金 深圳市科技计划项目(201103336) 深圳市新发传染病重点专科基金资助
关键词 鲍曼不动杆菌 碳青霉烯类抗生素 最低抑菌浓度 Acinetobacter baumannii carbapenem minimum inhibitory concentration
  • 相关文献

参考文献11

  • 1Choi WS,Kim SH,Jeon EG. Nosocomial outbreak of carbapenem-resistant Acinetobacter baumannii in Intensive Care Units and successful outbreak control program[J].Journal of Korean Medical Science,2010,(07):9991004.
  • 2Nemec A,Krizová L,Maixnerová M. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug resistant strains of European clone Ⅱ[J].Journal of Antimicrobial Chemotherapy,2008,(03):484-489.
  • 3汪复.多重耐药铜绿假单胞菌与鲍曼不动杆菌严重感染的防治策略[J].中国感染与化疗杂志,2007,7(3):230-232. 被引量:139
  • 4王辉,倪语星,陈民钧,胡必杰,王明贵,陈佰义,胡继红,胡云建.新型甘氨酰环素类抗菌药物替加环素的体外药敏试验操作规程[J].中华检验医学杂志,2009,32(11):1208-1213. 被引量:65
  • 5习慧明,徐英春,朱德妹,汪复,倪语星,孙景勇,孙自镛,简翠,胡云建,艾效曼,张泓,李万华,贾蓓,黄文祥,王传清,王爱敏,魏莲花,吴玲,卓超,苏丹虹,张朝霞,季萍,徐元宏,熊自忠,沈继录,单斌,杜艳,俞云松,杨青.2010年中国CHINET鲍曼不动杆菌耐药性监测[J].中国感染与化疗杂志,2012,12(2):98-104. 被引量:212
  • 6Perez F,Hujer AM,Hujer KM. Global Challenge of multidrug-resistant Acinetobacter baumannii[J].Antimicrobial Agents and Chemotherapy,2007,(10):3471-3484.
  • 7Zhou H,Yang Q,Yu YS. Clonal spread of imipenemresistant Acinetobacter baumannii among different cities of China[J].Journal of Clinical Microbiology,2007,(12):4054-4057.
  • 8Torrico M,Gonzalez N,Gimenez MJ. Influence of media and testing methodology on susceptibility to tigecycline of Enterobacteriaceae with reported high tigecycline MIC[J].Journal of Clinical Microbiology,2010,(06):2243-2246.
  • 9崔俊昌,宋秀杰.不同MH琼脂对于替加环素对鲍曼不动杆菌药敏结果的影响[J].中国药物应用与监测,2012,9(2):84-86. 被引量:13
  • 10Bassetti M,Righi E,Esposito S. Drug treatment for multidrug-resistant Acinetobacter baumannii infections[J].Future Microbiol,2008,(06):649-660.

二级参考文献46

  • 1张小江,徐英春,俞云松,杨青,汪复,朱德妹,倪语星,孙景勇,孙自镛,简翠,胡云建,艾效曼,张泓,李万华,贾蓓,黄文祥,王传清,王爱敏,魏莲花,吴玲,卓超,苏丹虹,张朝霞,季萍,徐元宏,熊自忠,沈继录,单斌,杜艳.2009年中国CHINET鲍曼不动杆菌细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):441-446. 被引量:137
  • 2Petersen PJ, Jacobus NV, Weiss WJ, et al. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrob Agents Chemother, 1999, 43:738-744.
  • 3Bradford P. Tigecycline: a first in class glycylcycline. Clin Micro Newsl, 2004,26:163-168.
  • 4Felmingham D. Tigecycline-the first glycylcycline to undergo clinical development: an overview of in vitro activity compared to tetracycline. J Chemother, 2005,17 Suppl 1:5-11.
  • 5Chopra I, Hawkey PM, Hinton M. Tetracyclines, molecular and clinical aspects. J Antimicrob Chemother,1992 ,29 :245-277.
  • 6Schnappinger D, Hillen W. Tetraeyclines: antibiotic action, uptake, and resistance mechanisms. Arch Mierobiol, 1996, 165:359-369.
  • 7Bauer G, Berens C, Projan SJ, et al. Comparison of tetracycline and tigecycline binding to ribosomes mapped by dimethylsulphate and drugdirected Fe^2 + cleavage of 16S rRNA. J Antimicrob Chemother, 2004, 53:592-599.
  • 8Olson MW, Ruzin A, Feyfant E, et al. Functional, biophysical, and structural bases for antibacterial activity of tigecycline. Antimicrob Agents Chemother, 2006,50 : 2156 -2166.
  • 9Keeney D, Ruzin A, Bradford PA. RamA, a transcriptional regulator, and AcrAB, an RND-type efflux pump, are associated with decreased susceptibility to tigecycline in Enterobacter cloacae. Mierob Drug Resist, 2007,13:1-6.
  • 10Ruzin A, Visalli MA, Keeney D, et al. Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae. Antimicrob Agents Chemother,2005,49 : 1017-1022.

共引文献417

同被引文献179

引证文献19

二级引证文献120

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部